1. A DNA-binding factor specific for xenobiotic responsive elements of P-450c gene exists as a cryptic form in cytoplasm: its possible translocation to nucleus
- Author
-
Atsuko Fujisawa-Sehara, Miyuki Yamane, and Yoshiaki Fujii-Kuriyama
- Subjects
Cytoplasm ,Polychlorinated Dibenzodioxins ,Transcription, Genetic ,Receptors, Drug ,Mutant ,Biology ,chemistry.chemical_compound ,Cytochrome P-450 Enzyme System ,Transcription (biology) ,medicine ,Electrophoretic mobility shift assay ,Binding site ,Regulation of gene expression ,Cell Nucleus ,Multidisciplinary ,Binding Sites ,Base Sequence ,Biological Transport ,DNA ,Cell biology ,Cell nucleus ,medicine.anatomical_structure ,chemistry ,Biochemistry ,Xenobiotic ,Research Article ,Methylcholanthrene - Abstract
Transcription of the drug-metabolizing cytochrome P-450c gene is induced by 3-methylcholanthrene or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Previously, we defined two xenobiotic responsive elements (XREs) of approximately equal to 15 base pairs, both of which activate transcription in cis in response to these xenobiotics. Using a gel mobility shift assay, we have identified a factor that specifically binds to the XREs. This factor appears in nuclei of mouse hepatoma cell line Hepa-1 only when the cells are treated with the xenobiotics, while the factor is undetectable in the nuclei of a 3-methylcholanthrene-treated mutant of Hepa-1 with defective function of a xenobiotic receptor. In addition, the nuclear factor bound to the XRE in the gel was found to be associated with [3H]TCDD when the cells were treated with it, suggesting that the xenobiotic receptor is at least a component of the DNA-binding factor. The cytoplasmic fraction from nontreated Hepa-1 cells also contains the factor as a cryptic form and prominently reveals its DNA-binding activity by incubation with 3-methylcholanthrene in vitro. These results not only suggest the involvement of the XRE-binding factor in transcriptional activation via XREs but also provide evidence that the binding of ligands to the preexisting factor in a cryptic form induces its XRE-binding activity, which is probably followed by its translocation from cytoplasm to nucleus.
- Published
- 1988